Novartis (NYSE:NVS) reported quarterly earnings of $1.26 per share which missed the analyst consensus estimate of $1.99 by 36.52 percent. This is a 36.36 percent decrease over earnings of $1.98 per share from the same period last year. The company reported quarterly sales of $13.336 billion which missed the analyst consensus estimate of $13.781 billion by 3.23 percent. This is a 1.39 percent increase over sales of $13.153 billion the same period last year.